Richmond County, Ga., funds by Health and Human Services, Department of
Listing $17,823,124.51 in stimulus funds from Health and Human Services, Department of for Richmond
Note: For some programs where states do not report where money will be distributed across the state, we do not have the allocation for individual counties. Those programs include: Medicaid, unemployment benefits and food stamps. Those amounts are included in the totals for where the state agency receiving that money is located.
Amount refers to both the amount of stimulus funding going toward the project and the face value of the loan.
| Recipient | Amount | Description | Federal Dept./Agency | Date |
|---|---|---|---|---|
| CSRA ECONOMIC OPPORTUNITY AUTHORITY INC | $1,780,220 |
ARRA - Community Services Block Grant ARRA Supplemental Funding for the Community Services Block Grant (CSBG) Program: The CSBG ARRA grant was primarily used to prevent homelessness and provide employment and employment supports.
This spending item is part of a $26,896,180 allocation.
See details
|
Administration for Children and Families | 4/10/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $996,327 | Trans-NIH Recovery Act Research Support One of the major obstacles in our understanding of memory ageing is lack of an effective tool to address the fundamental questions such as: what are memory traces? What are the major alterations in the network-level dynamics and memory-encoding patterns d | National Institutes of Health | 9/24/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $825,532 |
Trans-NIH Recovery Act Research Support High-throughput screen for FDA approved drugs that amplify Beta-cell mass in vivo The aim of the project proposed here is to identify drugs that will be therapeutic in the treatment of Diabetes. Type I (or Juvenile) Diabetes is caused by a chronic loss of
This spending item is part of a $2,524,394 allocation.
See details
|
National Institutes of Health | 9/30/2010 |
| CSRA ECONOMIC OPPORTUNITY AUTHORITY INC | $793,311 | ARRA - Head Start Head Start 2009 ARRA COLA Quality Improvement Funding. | Administration for Children and Families | 7/01/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $791,398 |
Trans-NIH Recovery Act Research Support The overall goal of these continuing studies is to understand how endothelial nitric oxide synthase (eNOS) signaling is regulated in the pulmonary system with emphasis on its role in the perinatal period. We have recently demonstrated in vivo, that endoth
This spending item is part of a $977,179 allocation.
See details
|
National Institutes of Health | 8/31/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $735,000 | Trans-NIH Recovery Act Research Support Hypertension and the associated renal and cardiovascular complications are a serious health problem in the Unites States. Approximately 65% of hypertensive patients do not have their blood pressure controlled and women are more likely than men to have unc | National Institutes of Health | 6/01/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $735,000 | Trans-NIH Recovery Act Research Support The paradigm that inflammation stimulates adaptive immunity is well established. Paradoxically, mounting evidence reveals that some forms of inflammation create local suppression, particularly in tissues subjected to chronic inflammation caused by persist | National Institutes of Health | 5/21/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $735,000 | Trans-NIH Recovery Act Research Support Repertoire of antigen receptors (TCRs) on T cells is shaped by interactions between TCRs and MHC molecules bound with peptides of self and non-self origin. In thymus, these interactions promote differentiation of T cells with TCRs with low/intermediate af | National Institutes of Health | 7/22/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $731,214 | Trans-NIH Recovery Act Research Support The long-term goal of this project is to elucidate the functional roles of glycosphingolipids (GSLs), particularly gangliosides, during normal nervous system development and under pathological conditions. These molecules are abundant in the nervous system | National Institutes of Health | 7/15/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $718,550 | Trans-NIH Recovery Act Research Support We previously reported that sodium excretion is significantly correlated to the excretion of nitrate/nitrite (metabolites of nitric oxide) in normotensive young adults. This association of the nitric oxide pathway with sodium excretion in humans led us to | National Institutes of Health | 6/01/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $510,370 | Trans-NIH Recovery Act Research Support DNA methylation is an essential regulator of transcription, chromatin structure, development, and genomic stability in mammalian cells that is mediated by a family of DNA methyltransferases (DNMTs): DNMT1, DNMT3A, and DNMT3B. While normal patterns are cri | National Institutes of Health | 7/17/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $494,750 | Trans-NIH Recovery Act Research Support The major goal of the current proposal is to obtain funds for the purchase of a Becton Dickinson FACSAria II Cell Sorter Flow Cytometer (BD-FACS) system, including a Becker BioPROtect III Bio-containment enclosure that is specifically designed for analyse | National Institutes of Health | 6/28/2010 |
| MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE INC | $464,440 | Trans-NIH Recovery Act Research Support Funding is requested for the purchase of an Amnis ImageStream multispectral imaging flow cytometer which can perform high-throughput analysis of cell populations and cellular processes. This instrument essentially combines the visual power of microscopy, | National Institutes of Health | 3/11/2010 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $445,343 |
Trans-NIH Recovery Act Research Support The Coordinating and Bioinformatics Unit (CBU) for the Animal Models of Diabetic Complications Consortium (AMDCC) and the Mouse Metabolic Phenotyping Centers (MMPC) is responsible for creating and maintaining the administrative, scientific and informatics
This spending item is part of a $1,819,749 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $404,250 | Trans-NIH Recovery Act Research Support The long-term objective of the application is to understand how emotional experiences alter memory acquisition and consolidation processes in the forebrain. The PI was instrumental in developing recent technological advances that allow powerful within-ani | National Institutes of Health | 5/14/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $404,250 | Trans-NIH Recovery Act Research Support : The long-term aim of to limit disease in man. Toward this goal, we will take advantage of: the restricted nature of 13(IV) collagen (13(IV) and its available epitopes with the kidney; the availability of a unique panel of human monoclonal antibodies (mA | National Institutes of Health | 9/24/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $404,250 | Trans-NIH Recovery Act Research Support The prevalence of hypertension and cardiovascular disease has increased in recent decades in parallel with increasing obesity. This project explores the hypothesis that a person's physical activity levels influence expression of receptors for leptin, a ho | National Institutes of Health | 5/15/2009 |
| NEIGHBORHOOD IMPROVEMENT PROJECT, INC. | $336,345 | ARRA Health Center Integrated Services Development Initiative[g1] ARRA - Capital Improvement Project | Health Resources and Services Administration | 6/25/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $330,750 | Trans-NIH Recovery Act Research Support Novel therapeutic strategies such as modulation of dendritic cell and T cell functions have shown great potential in clinical transplantation. HLA-G is a molecule that plays a significant role in establishing complex mechanisms to protect semi-allogeneic | National Institutes of Health | 9/01/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $327,900 | Trans-NIH Recovery Act Research Support Campylobacter jejuni is a leading bacterial cause of gastroenteritis in the United States, and is responsible for sporadic disease as well as food-borne and water-borne outbreaks. It is also a Category B Bioterrorism Agent. There are at least 2 million | National Institutes of Health | 7/19/2010 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $282,897 | Trans-NIH Recovery Act Research Support The stress response is an evolutionary conserved cellular response mechanism characterized by the enhanced synthesis and accumulation of heat shock proteins (Hsps). These proteins act as molecular chaperones and prevent aggregation of misfolded proteins; | National Institutes of Health | 8/27/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $256,075 | Trans-NIH Recovery Act Research Support Cardiovascular disease is the leading cause of death for both men and women in the United States and the world. There is a profound pattern in the time of day at which the death occurs. It is in the morning, when the endothelium is most vulnerable and blo | National Institutes of Health | 7/16/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $237,850 | Trans-NIH Recovery Act Research Support The main focus of this study is to characterize the cellular mechanisms underlying functional hyperemia in the cerebral cortex. Functional hyperemia occurs as a function of the communication between neurons, astrocytes and the cerebral microcirculation. D | National Institutes of Health | 7/16/2009 |
| MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE INC | $228,218 | Trans-NIH Recovery Act Research Support The long-term goal of proposed research is to understand the physiological role of zinc finger protein ZPR1 complexes in cell growth and development. ZPR1 interacts with survival motor neuron (SMN) and eukaryotic translation elongation factor 1A (eEF1A) p | National Institutes of Health | 5/04/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $224,522 | Trans-NIH Recovery Act Research Support The long-term goal of our laboratory is to understand molecular mechanisms underlying the formation and maintenance of synapses. Our model is the NMJ, a cholinergic synapse between motoneurons and muscle cells. The NMJ exhibits the high degree of subcellu | National Institutes of Health | 9/25/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $220,500 | Trans-NIH Recovery Act Research Support Sjogren's syndrome (SS) is a complex autoimmune disorder causing dysfunction of the salivary and lacrimal glands, leading to dry mouth and dry eyes. SS is also associated with rheumatic disorders such as rheumatoid arthritis. The cause of SS is unknown an | National Institutes of Health | 8/21/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $218,496 | Trans-NIH Recovery Act Research Support Supplemental funding will support a new specific aim that will allow us to extend our studies on adrenal zonation into transgenic mouse models. The human adrenal cortex can be divided into distinct zones that have both morphologic and biochemical differe | National Institutes of Health | 9/18/2009 |
| CSRA ECONOMIC OPPORTUNITY AUTHORITY INC | $198,499 | ARRA - Head Start ARRA Early Learning Mentor Coach | Administration for Children and Families | 9/15/2010 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $196,680 | Trans-NIH Recovery Act Research Support Lymph node involvement is one of the most important clinical features to determine when managing colorectal cancer patients. Node-negative disease is often cured by surgery alone, whereas node-positive disease requires the administration of chemotherapy, | National Institutes of Health | 8/11/2010 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $195,589 |
Trans-NIH Recovery Act Research Support This application addresses broad Challenge Are (06) Enabling Technologies and Specific Challenge Topic 06-CA-106 Data integration and visualization methods and tools. Prostate cancer is a highly prevalent disease in older men of the Western world, whose i
This spending item is part of a $998,992 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
| MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE INC | $174,554 | Trans-NIH Recovery Act Research Support Campylobacter infections constitute the most common bacterial form of gastroenteritis in the US, however, an effective vaccine against campylobacteriosis is not currently available. In the parent grant, significant progress was made toward the identific | National Institutes of Health | 9/11/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $163,370 |
Trans-NIH Recovery Act Research Support This Competitive Revision application proposes an additional Specific Aim for the original R01 project of the same title. The long term goal of our project is to define the development of signaling networks that induce differentiation of cells into mature
This spending item is part of a $388,219 allocation.
See details
|
National Institutes of Health | 9/21/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $156,450 | Trans-NIH Recovery Act Research Support The Animal Models of Diabetic Complications Consortium (AMDCC) and the Mouse Metabolic Phenotyping Centers (MMPC) are two multi-center initiatives funded by the NIH. During the current five year funding cycle, the AMDCC had the primary responsibility of d | National Institutes of Health | 9/30/2010 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $153,332 |
Trans-NIH Recovery Act Research Support The Animal Models of Diabetic Complications Consortium (AMDCC) and the Mouse Metabolic Phenotyping Centers (MMPC) are two multi-center initiatives funded by the NIH. During the current five year funding cycle, the AMDCC had the primary responsibility of d
This spending item is part of a $343,182 allocation.
See details
|
National Institutes of Health | 9/30/2010 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $150,053 | Trans-NIH Recovery Act Research Support The dorsoventral axis of the Drosophila embryo is established by ventral activation of the Toll signaling pathway, resulting in the graded nuclear uptake of the Dorsal transcription factor. Pathway activation relies on a ventral cue synthesized during oog | National Institutes of Health | 9/18/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $147,000 | Trans-NIH Recovery Act Research Support The overall goal of this project is to examine the effects of cocaine dependency on renal physiology in African Americans (AAs). Cocaine-dependent AAs are at risk for sub-clinical renal damage resulting from cocaine use, yet little data exists to guide cl | National Institutes of Health | 5/07/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY, INC. | $145,496 | ARRA ? Equipment to Enhance Training for Health Professionals Georgia currently has one of the highest total designation counts for HPSA areas and has approximately 50% of its population with underserved population status, 2010). To help fill in the gaps made by this need, the Department of Family MeMedicine (DFM) at ... Show more | Health Resources and Services Administration | 9/03/2010 |
| MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE INC | $145,288 | Trans-NIH Recovery Act Research Support The goal of the current proposal is to obtain funds for the purchase of a high-resolution ultrasound micro- imaging system designed specifically for non-invasive small animal research. The Visualsonics Vevo 770 offers spatial resolution down to 30 microns | National Institutes of Health | 4/28/2009 |
| NEIGHBORHOOD IMPROVEMENT PROJECT, INC. | $135,486 | ARRA Health Center Integrated Services Development Initiative[g1] Grant Name:Increased Demand for Services Purpose: To increase access to primary health care for the uninsured and underinsured in order to reduce suffering, increase productivity and lower ultimate costs for health care. Goals: to prprovide primary health... Show more | Health Resources and Services Administration | 3/27/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $129,614 |
Trans-NIH Recovery Act Research Support Heart disease is the leading cause of death in Georgia, and diabetics, the elderly, and African American women are most at risk. The cardiac stress test is the standard screening tool for assessing cardiac function, and electrocardiography (ECG), ultrasou
This spending item is part of a $381,100 allocation.
See details
|
National Institutes of Health | 6/14/2010 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $104,300 | Trans-NIH Recovery Act Research Support Our long-term goal is to elucidate the roles of a novel protein C53 in regulation of cell cycle progression and DNA damage response, and to explore potential utilization of this novel protein as a novel therapeutic approach. Regulation of cell cycle and c | National Institutes of Health | 8/23/2010 |
| MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE INC | $100,000 | Trans-NIH Recovery Act Research Support Within the human adrenal, the zona glomerulosa produces aldosterone, the fasciculata produces cortisol and the reticularis produces the adrenal androgens, mainly DHEA and DHEA-sulfate. Adrenarche refers to the onset of adrenal reticularis production of a | National Institutes of Health | 1/15/2010 |
| MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE INC | $100,000 | Trans-NIH Recovery Act Research Support The Environmental Determinants of Diabetes in the Young (TEDDY), a multicenter prospective cohort study, was initiated in 2003 to identify environmental factors that trigger or protect against the development of islet autoimmunity and type 1 diabetes (T1D | National Institutes of Health | 1/26/2010 |
| MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE INC | $99,710 | Trans-NIH Recovery Act Research Support The purpose of this supplemental funding request is to acquire sufficient additional equipment to build a second widefield fluorescence recovery after photobleaching (FRAP) workstation with the ability to photoactivate proteins at 405nm. This equipment w | National Institutes of Health | 6/11/2010 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $92,806 |
The Systolic Blood Pressure Intervention Trial (SPRINT)-Senior ARRA expansion is designed to test the SPRINT intervention in participants who are ? 75 years of age. Approximately 3,250 of the 9,250 SPRINT participants are expected to be age 75 or older. I
This spending item is part of a $2,671,616 allocation.
See details
|
National Institutes of Health | 9/24/2010 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $80,178 | Trans-NIH Recovery Act Research Support Polycystic ovary syndrome (PCOS) affects approximately 7% of reproductive-aged women, and is one of the most common causes of oligo-ovulatory infertility. Insulin resistance occurs in about 70% of women with PCOS, and contributes to much of the hyperandro | National Institutes of Health | 1/27/2011 |
| MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE INC | $71,558 | Trans-NIH Recovery Act Research Support The purpose of this application is to request salary support for retaining an experienced postdoctoral fellow, Dr. Nianlan Yang. Dr. Yang is intelligent, had very good training in molecular biology and excellent track record. With this support, Dr. Yang | National Institutes of Health | 3/15/2010 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $71,094 | Medical College of Georgia has been awarded a contract to provide tumor types to the NCI for The Cancer Genome Atlas (TCGA) project. Specifically this award is to fund the provision of thyroid and oral cavity squamous cell carcinoma (OSCC) tissue (40 tot | National Institutes of Health | 8/26/2010 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $69,736 |
Trans-NIH Recovery Act Research Support This study will determine whether exercise training influences cognition in overweight children when compared to an attention control condition. This area of research is particularly important due to the increasing rate of overweight and its sequelae amon
This spending item is part of a $235,193 allocation.
See details
|
National Institutes of Health | 9/24/2010 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $67,160 |
Trans-NIH Recovery Act Research Support Alzheimer's disease is characterized by the aggregation of 13-amyloid (A13) protein in the brain, widespread neurodegeration, and cognitive decline. Our work focuses on amelioration of Alzheimer's pathology by reducing or simplifying the major brain gang
This spending item is part of a $945,128 allocation.
See details
|
National Institutes of Health | 9/04/2009 |
| MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE INC | $66,390 | Trans-NIH Recovery Act Research Support The long-term goal of our program is to better understand the regulation of cerebrovascular function and structure, in order to identify new targets and develop new strategies for prevention and treatment of stroke in diabetes. The central hypothesis of | National Institutes of Health | 9/18/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $57,830 |
Trans-NIH Recovery Act Research Support The goal of this research was to follow up the families in an established multi-ethnic birth cohort by phone interview when the subject children are turning 3-7 yrs of age to ascertain the incidence of asthma and allergic conditions and longitudinal data
This spending item is part of a $744,233 allocation.
See details
|
National Institutes of Health | 8/14/2009 |
| MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE INC | $53,600 | Trans-NIH Recovery Act Research Support The overall goal of this project involves the establishment and analysis of a new autoimmune(AI) mouse model where T cells that are self-reactive escape deletion due to a defect in the presentation of tissue specific antigens (TSAs) in the thymus. The Aut | National Institutes of Health | 7/23/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $36,144 |
Trans-NIH Recovery Act Research Support This study seeks to elucidate the mechanistic basis of immune responses to factor VIII (FVIII) in some but not all hemophilia A (HA) patients and the increased risk of HA patients with black African ancestry for developing that complication following ther
This spending item is part of a $6,507,463 allocation.
See details
|
National Institutes of Health | 9/24/2009 |
| RICHMOND, COUNTY OF | $15,000 |
ARRA - Prevention and Wellness--State Territories and Pacific Islands The Georgia Department of Community Health, Division of Public Health, Healthy Communities Initiative focuses on implementing evidence-based policy and environmental changes to support and institutionalize healthy behaviors relateted to obesity, physical ac... Show more
This spending item is part of a $1,268,574 allocation.
See details
|
Centers for Disease Control and Prevention | 2/04/2010 |
| RICHMOND, COUNTY OF | $9,450 |
ARRA - Immunization Georgia Immunization Program used ARRA funding to increase vaccine availability and services to adults and adolescents and increase the capacity of for data collection for Public Health Immunization data systems. The Georgia WIC program serves approximat
This spending item is part of a $1,850,152 allocation.
See details
|
Centers for Disease Control and Prevention | 9/28/2009 |
| GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC. | $2,000 |
Trans-NIH Recovery Act Research Support This is a translational research proposal to elucidate the mechanisms underlying apparent differences in end-organ iron deposition between patients with sickle cell anemia (SCD), thalassemia (TM) and Diamond Blackfan Anemia (DBA). Increasing numbers of
This spending item is part of a $645,010 allocation.
See details
|
National Institutes of Health | 9/10/2009 |
| MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE INC | $2,000 |
Trans-NIH Recovery Act Research Support This is a translational research proposal to elucidate the mechanisms underlying apparent differences in end-organ iron deposition between patients with sickle cell anemia (SCD), thalassemia (TM) and Diamond Blackfan Anemia (DBA). Increasing numbers of
This spending item is part of a $645,010 allocation.
See details
|
National Institutes of Health | 9/10/2009 |